189 related articles for article (PubMed ID: 36263180)
1. HDAC5-mediated Smad7 silencing through MEF2A is critical for fibroblast activation and hypertrophic scar formation.
Gao Y; Liu Y; Zheng D; Ho C; Wen D; Sun J; Huang L; Liu Y; Li Q; Zhang Y
Int J Biol Sci; 2022; 18(15):5724-5739. PubMed ID: 36263180
[TBL] [Abstract][Full Text] [Related]
2. Smad7 down-regulation via ubiquitin degradation mediated by Smurf2 in fibroblasts of hypertrophic scars in burned patients.
Zhang Z; Liu C; Chen B; Tang W; Liu Z; Cao W; Li X
Burns; 2021 Sep; 47(6):1333-1341. PubMed ID: 33436154
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sphingosine kinase 2 attenuates hypertrophic scar formation via upregulation of Smad7 in human hypertrophic scar fibroblasts.
Zeng J; Jiang B; Xiao X; Zhang R
Mol Med Rep; 2020 Sep; 22(3):2573-2582. PubMed ID: 32705254
[TBL] [Abstract][Full Text] [Related]
4. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1.
Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P
Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749
[TBL] [Abstract][Full Text] [Related]
5. Fibroproliferative effect of microRNA-21 in hypertrophic scar derived fibroblasts.
Li G; Zhou R; Zhang Q; Jiang B; Wu Q; Wang C
Exp Cell Res; 2016 Jul; 345(1):93-9. PubMed ID: 27207585
[TBL] [Abstract][Full Text] [Related]
6. mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity.
Lemercier C; Verdel A; Galloo B; Curtet S; Brocard MP; Khochbin S
J Biol Chem; 2000 May; 275(20):15594-9. PubMed ID: 10748098
[TBL] [Abstract][Full Text] [Related]
7. TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis.
Hu ZC; Shi F; Liu P; Zhang J; Guo D; Cao XL; Chen CF; Qu SQ; Zhu JY; Tang B
J Invest Dermatol; 2017 May; 137(5):1051-1059. PubMed ID: 28108300
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts.
Kopp J; Preis E; Said H; Hafemann B; Wickert L; Gressner AM; Pallua N; Dooley S
J Biol Chem; 2005 Jun; 280(22):21570-6. PubMed ID: 15788410
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5.
He T; Huang J; Chen L; Han G; Stanmore D; Krebs-Haupenthal J; Avkiran M; Hagenmüller M; Backs J
J Mol Cell Cardiol; 2020 Aug; 145():88-98. PubMed ID: 32485181
[TBL] [Abstract][Full Text] [Related]
10. Smad interacting protein 1 influences transforming growth factor-β
Fang X; Hu X; Zheng Z; Tao K; Wang H; Guan H; Shi J; Ji P; Cai W; Bai X; Zhu X; Han J; Liu J; Hu D
J Mol Histol; 2019 Dec; 50(6):503-514. PubMed ID: 31595443
[TBL] [Abstract][Full Text] [Related]
11. The Effects of the Transforming Growth Factor-β1 (TGF-β1) Signaling Pathway on Cell Proliferation and Cell Migration are Mediated by Ubiquitin Specific Protease 4 (USP4) in Hypertrophic Scar Tissue and Primary Fibroblast Cultures.
Huang Y; Wang Y; Wang X; Lin L; Wang P; Sun J; Jiang L
Med Sci Monit; 2020 Apr; 26():e920736. PubMed ID: 32308208
[TBL] [Abstract][Full Text] [Related]
12. Effect of tetrandrine on the TGF-β-induced smad signal transduction pathway in human hypertrophic scar fibroblasts in vitro.
Zunwen L; Shizhen Z; Dewu L; Yungui M; Pu N
Burns; 2012 May; 38(3):404-13. PubMed ID: 21925794
[TBL] [Abstract][Full Text] [Related]
13. Exercise increases the binding of MEF2A to the Cpt1b promoter in mouse skeletal muscle.
Yuan H; Niu Y; Liu X; Fu L
Acta Physiol (Oxf); 2014 Dec; 212(4):283-92. PubMed ID: 25213552
[TBL] [Abstract][Full Text] [Related]
14. LncRNA COL1A2-AS1 inhibits the scar fibroblasts proliferation via regulating miR-21/Smad7 pathway.
Nong Q; Li S; Wu Y; Liu D
Biochem Biophys Res Commun; 2018 Jan; 495(1):319-324. PubMed ID: 29117538
[TBL] [Abstract][Full Text] [Related]
15. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts.
Qin Z; Xia W; Fisher GJ; Voorhees JJ; Quan T
Cell Commun Signal; 2018 Apr; 16(1):18. PubMed ID: 29695252
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA HECTD1 knockdown inhibits transforming growth factor-beta/ small mothers against decapentaplegic (TGF-β/Smad) signaling to reduce hypertrophic scar fibrosis.
Ge X; Sun Y; Tang Y; Lin J; Zhou F; Yao G; Su X
Bioengineered; 2022 Mar; 13(3):7303-7315. PubMed ID: 35246019
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-4 critically controls transforming growth factor β1 induced hypertrophic scar formation.
Qian W; Li N; Cao Q; Fan J
J Cell Physiol; 2018 Jan; 234(1):731-739. PubMed ID: 30132849
[TBL] [Abstract][Full Text] [Related]
18. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
19. Association between MeCP2 and Smad7 in the pathogenesis and development of pathological scars.
Li D; Yang E; Zhao J; Zhang H
J Plast Surg Hand Surg; 2021 Oct; 55(5):284-293. PubMed ID: 33475023
[TBL] [Abstract][Full Text] [Related]
20. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein.
Boyer Arnold N; Korc M
J Biol Chem; 2005 Jun; 280(23):21858-66. PubMed ID: 15811853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
